You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mfolfox

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Cancer Trial (GEN-001, Pembrolizumab, mFOLFOX)

Not yet recruiting
  • Biliary Tract Cancer
  • (no location specified)
Aug 16, 2023

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Biliary Tract Cancer Trial in Kaohsiung, Taichung (D07001-softgel capsules + Xeloda (or TS-1), mFOLFOX)

Recruiting
  • Biliary Tract Cancer
  • D07001-softgel capsules + Xeloda (or TS-1)
  • mFOLFOX
  • Kaohsiung, Taiwan
  • +4 more
Dec 22, 2022

Rectal Cancer Trial in Beijing (combination product, drug, procedure)

Recruiting
  • Rectal Cancer
  • Concurrent Chemoradiotherapy
  • +3 more
  • Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Jan 23, 2022

Adenocarcinoma of the Stomach, GastroEsophageal Cancer Trial in Germany (Nivolumab, Ipilimumab, mFOLFOX)

Active, not recruiting
  • Adenocarcinoma of the Stomach
  • GastroEsophageal Cancer
  • Amberg, Germany
  • +26 more
Jan 12, 2023

Colorectal Tumors Trial in Worldwide (BIBF 1120, mFolfox, Bevacizumab)

Completed
Has Results
  • Colorectal Neoplasms
  • BIBF 1120
  • +4 more
  • Bonheiden, Belgium
  • +46 more
Feb 3, 2015

Stomach Tumors, Gastric Cancer Trial in Beijing (mFOLFOX)

Unknown status
  • Stomach Neoplasms
  • Gastric Cancer
  • mFOLFOX
  • Beijing, Beijing, China
    Peking University School of Oncology
Jan 10, 2008